- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Do | GlucoTrack And 2 Other Stocks Under $1 Insiders Are Buying | 1 | Benzinga.com | ||
| 22.04. | GlucoTrack, Inc.: GLUCOTRACK ANNOUNCES CLOSING OF PRIVATE PLACEMENT | 1 | GlobeNewswire (USA) | ||
| 16.04. | Glucotrack expands CGM tech to spinal epidural space | 1 | MassDevice | ||
| 16.04. | Glucotrack announces expansion into epidural glucose monitoring solutions | 1 | Seeking Alpha | ||
| 16.04. | GlucoTrack, Inc.: GLUCOTRACK ANNOUNCES EXPANSION OF ITS CONTINUOUS GLUCOSE MONITORING TECHNOLOGY TO EPIDURAL GLUCOSE MONITORING | 1 | GlobeNewswire (USA) | ||
| 02.04. | GlucoTrack, Inc.: GLUCOTRACK ANNOUNCES INCREASED SENSOR LONGEVITY FOR ITS IMPLANTABLE CONTINUOUS BLOOD GLUCOSE MONITOR | 3 | GlobeNewswire (USA) | ||
| 28.03. | GlucoTrack, Inc. - 10-K, Annual Report | 2 | SEC Filings | ||
| 12.03. | GlucoTrack, Inc.: GLUCOTRACK EXPANDS LEADERSHIP TEAM WITH NEW VICE PRESIDENT OF QUALITY | 1 | GlobeNewswire (USA) | ||
| 27.02. | GlucoTrack, Inc.: Glucotrack Selects Cirtec Medical As Manufacturer For Its Implantable Continuous Blood Glucose Monitor | 305 | GlobeNewswire (Europe) | Rutherford, NJ & Brooklyn Park, MN, Feb. 27, 2024 (GLOBE NEWSWIRE) -- Glucotrack, Inc. (Nasdaq: GCTK), a medical device company focused on the design, development, and commercialization of novel technologies... ► Artikel lesen | |
| 16.02. | GlucoTrack, Inc. - 8-K, Current Report | 3 | SEC Filings | ||
| 13.02. | Glucotrack appoints new chairman with MedTech experience | 1 | Investing.com | ||
| 13.02. | Glucotrack names Luis Malavé board chair | 1 | Seeking Alpha | ||
| 13.02. | GlucoTrack, Inc.: GLUCOTRACK ANNOUNCES THE APPOINTMENT OF LUIS MALAVÉ TO CHAIR OF THE BOARD OF DIRECTORS | 1 | GlobeNewswire (USA) | ||
| 13.02. | Wiener Börse zu Mittag stärker: S Immo, Pierer Mobility und FACC gesucht, in Deutschland Rheinmetall, dazu IRW-News zu GlucoTrack | 538 | boerse-social.com | Heute im gabb: Um 11:54 liegt der ATX mit +0.11 Prozent im Plus bei 3391 Punkten (Ultimo 2023: 3435, -1.29% ytd). Topperformer der PIR-Group sind S Immo mit +1.71% auf 14.87 Euro, dahinter Pierer Mobility... ► Artikel lesen | |
| 09.02. | Wiener Börse zu Mittag schwächer: FACC, Palfinger und Do&Co gesucht, in Deutschland Daimler Truck dazu IRW-News zu GlucoTrack | 802 | boerse-social.com | Heute im gabb: Um 12:45 liegt der ATX mit -0.44 Prozent im Minus bei 3354 Punkten (Ultimo 2023: 3435, -2.35% ytd). Topperformer der PIR-Group sind FACC mit +1.86% auf 5.745 Euro, dahinter Palfinger... ► Artikel lesen | |
| 08.02. | GlucoTrack veröffentlicht die ersten Daten zur Messgenauigkeit seines implantierbaren Geräts für die kontinuierliche Glukoseüberwachung | 410 | IR-WORLD | Rutherford, New Jersey, 2. Januar 2024 / IRW-Press / - GlucoTrack, Inc. (Nasdaq: GCTK) ("GlucoTrack" oder das "Unternehmen"), ein Medizintechnikunternehmen, das
auf die Konzeption, Entwicklung... ► Artikel lesen | |
| 11.01. | GlucoTrack, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 03.01. | GlucoTrack's 2-year implantable CGM boasts high accuracy in early tests, paving the way for human trials | 1 | FierceBiotech | ||
| 02.01. | Glucotrack has positive data for implantable continuous blood glucose monitor | 1 | MassDevice | ||
| 02.01. | GlucoTrack, Inc. - 8-K, Current Report | 1 | SEC Filings |
Seite:
1 2 Weiter >>
29 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| SERNOVA | 0,295 | -2,96 % | Sernova begrüßt den von Evotec nominierten Dr. Bernd Mühlenweg in seinem Board of Directors | - Dr. Daniel Mahony tritt von seinem Posten zurück, um sich neuen Aufgaben zu widmen
LONDON, ONTARIO; BOSTON, MASSACHUSETTS, den 22. April 2024 / IRW-Press / - Sernova Corp.... ► Artikel lesen | |
| SYNLAB | 10,500 | 0,00 % | Knorr-Bremse, Steico, Synlab, Börse München - 4investors Aktien Top-News | Wo ist am Aktienmarkt etwas los, welche Themen interessieren Anleger derzeit besonders? Vor allem für Trader ist es wichtig zu wissen, wo "die Musik spielt" und welche Themen an der Börse aktuell besonders... ► Artikel lesen | |
| NUGEN MEDICAL DEVICES | 0,077 | +0,52 % | NuGen Medical Devices Inc.: NuGen Announces Debt Settlement and Amendments to Care4Pharma Share Purchase Agreement | Toronto, Ontario--(Newsfile Corp. - April 15, 2024) - NuGen Medical Devices Inc. (TSXV: NGMD) (the "Company" or "NuGen") announces that it has agreed to settle an aggregate of €275,000 of indebtedness... ► Artikel lesen | |
| EVOFEM BIOSCIENCES | - | - | Evofem Biosciences, Inc.: Evofem Reports $18.2 million of Phexxi Net Product Sales in 2023 | -- Third Consecutive Year of Phexxi Net Sales Growth --
-- Total Operating Expense Reduced 64% from 2022 Levels --
-- Sales and marketing expense as a percentage of net sales was 54% for the fourth... ► Artikel lesen | |
| SONOMA PHARMACEUTICALS | 0,138 | 0,00 % | Sonoma Pharmaceuticals, Inc.: Sonoma Pharmaceuticals Announces Expansion of Negative-Pressure Wound Therapy Products for Use in the United States | BOULDER, CO / ACCESSWIRE / April 9, 2024 / Sonoma Pharmaceuticals, Inc. (Nasdaq:SNOA), a global healthcare leader developing and producing patented Microcyn® technology based stabilized hypochlorous... ► Artikel lesen | |
| CO-DIAGNOSTICS | 1,050 | +0,96 % | Co-Diagnostics, Inc. Reports Full Year 2023 Financial Results | SALT LAKE CITY, March 14, 2024 /PRNewswire/ -- Co-Diagnostics, Inc. (NASDAQ: CODX), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic... ► Artikel lesen | |
| ORPEA | 12,582 | -0,66 % | EMEIS PURSUES ITS REFOUNDATION: 2023 Consolidated Financial Results of ORPEA S.A. | Significant improvement in non-financial indicators, with major advances for employees, residents and patients
Health and safety: decline in the work-related accident frequency rate, at 24.8... ► Artikel lesen | |
| MEDIVOLVE | 0,003 | 0,00 % | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 23.02.2024 | The following instruments on Boerse Frankfurt do have their last trading day on 23.02.2024.Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 23.02.2024.ISIN NameCA58503M4083 MEDIVOLVE... ► Artikel lesen | |
| QUIDELORTHO | 37,000 | -0,54 % | QuidelOrtho Reports Fourth Quarter and Full-Year 2023 Financial Results | SAN DIEGO--(BUSINESS WIRE)--QuidelOrtho Corporation (Nasdaq: QDEL) (the "Company" or "QuidelOrtho"), a global provider of innovative in vitro diagnostic technologies designed for point-of-care... ► Artikel lesen | |
| QUEST DIAGNOSTICS | 128,60 | +2,51 % | Quest Diagnostics Foundation and Green Bronx Machine Expand Collaboration to Bring Acclaimed Indoor Gardening Curriculum to More Communities and Raise Awareness for Impact of Nutrition Education on Health Equity | Foundation grant will help NYC-based nonprofit expand reach of its innovative curriculum to 50 schools in Baltimore and Houston; funding will also support film screening tour of award-winning documentary... ► Artikel lesen | |
| TEMPEST THERAPEUTICS | 3,370 | +2,12 % | Tempest Therapeutics: Tempest Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) | BRISBANE, Calif., April 26, 2024 (GLOBE NEWSWIRE) -- Tempest Therapeutics, Inc. (Nasdaq: TPST), a clinical-stage biotechnology company developing first-in-class1 targeted and immune-mediated therapeutics... ► Artikel lesen | |
| VERU | 1,164 | -1,52 % | Veru Inc.: Veru to Present at the American Association of Clinical Endocrinology (AACE) 2024 Annual Meeting on May 9-11 | ||
| SENSEONICS | 0,391 | +0,88 % | Senseonics Holdings, Inc. Announces Data From the Eversense Post Approval Study to Be Presented at the 17th International Conference on Advanced Technologies and Treatments for Diabetes | Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring (CGM) systems for... ► Artikel lesen | |
| NANO-X IMAGING | 8,940 | +0,22 % | Nano-X Imaging Ltd. - 6-K, Report of foreign issuer | ||
| NUWELLIS, INC | 0,153 | -2,92 % | Nuwellis, Inc.: Nuwellis Announces Pricing of $2.7 Million Public Offering |
GLUCOTRACK INC gehört der Branche Gesundheitswesen an. Mit einer aktuellen Kursveränderung von -0,003 (-0,67 %) liegt der Kurs bei 0,457 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und
